Zymeworks (ZYME.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec12

Wells Fargo Analyst Gives Zymeworks a Buy Rating

10:42

Nov30

Zacks Research Downgrades Zymeworks Rating to 'Hold'

12:29

Nov21

Zymeworks Stock Upgraded by Multiple Firms, EPS Exceeds Expectations

23:20

Nov18

Zymeworks Inc. Optimizes Future Cash Flow Through Diversified Revenue Generation Assets

06:00

Nov17

Zymeworks Inc. Developing Novel Biologic Therapeutics for Refractory Diseases

12:07

Zymeworks Inc. Announces Positive Results from Ziihera's Phase III Clinical Trial for HER2-Positive Gastroesophageal Cancer

11:00

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 27.61 M, Net Income -19.6 M, EPS -0.2609

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 48.73 M, Net Income 2.317 M, EPS 0.0299

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 27.11 M, Net Income -22.64 M, EPS -0.3032

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change